ArticleMuscle & nerve2025

The epidermal growth factor receptor inhibitor gefitinib enhances in vitro and in vivo sensory axon regeneration and functional recovery following transection in a mouse median nerve injury model.

Maxwell Topley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.